Bliss GVS Pharma Peer Comparison

NSE: BLISSGVS | BSE: 506197

₹680.90

₹32.40 (5.00%)

As on 29-Oct-2026IST

Market cap

₹7,261 Cr

Revenue (TTM)

₹1,074 Cr

P/E Ratio

P/B Ratio

5.9

Div. Yield

0.2 %

Edit

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Market cap (₹ Cr)	7,261	16,145	7,346	6,140	2,106
Revenue (₹ Cr)	1,074	3,330	1,822	2,289	302
Net Profit (₹ Cr)	166.49	720.77	364.50	313.25	42.87
Net Margin (%)	14.84	21.60	19.81	12.91	14.09
RoE (%)	13.10	18.93	46.28	12.78	12.79
Price to Earnings	45.04	22.82	20.15	19.60	49.13
Price-To-Book	5.89	3.90	8.89	2.30	6.09

Income Statement (₹ Cr)

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Operating Revenue	927.11	3,129.42	1,837.40	2,170.93	251.74
Total Income	1,015.45	3,147.87	1,857.10	2,284.45	254.02
Total Expenditure	777.88	2,020.01	1,346.10	1,824.84	182.44
EBITDA	149.23	1,109.41	491.30	346.10	69.29
Depreciation	33.48	279.50	37.30	59.24	23.56
EBIT	115.75	829.91	454.00	286.86	45.73
Interest	12.01	192.67	1.70	4.99	8.26
Other Income	88.33	18.45	19.70	113.52	2.29
Exceptional Items	-2.49	-17.24	-27.30	-20.79	-0.05
Profit before Tax	189.59	638.54	444.70	374.60	39.76
Provision for Tax	54.86	-8.97	118.00	93.18	9.27
Profit after Tax	134.73	647.51	326.70	281.42	30.48

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Shareholder's Funds	1,192.90	3,902.67	749.20	2,485.11	324.45
Minority Interest	38.86	-7.01	--	--	--
Non-Current Liabilities	8.81	1,149.84	1,159.50	965.85	47.02
Current Liabilities	235.54	2,201.22	2,514.20	487.77	109.54
Total Liabilities	1,492.41	7,246.72	4,427.30	3,938.74	481.01

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Non-Current Assets	529.78	5,582.75	1,599.50	2,682.51	340.55
Current Assets	946.34	1,663.97	2,823.40	1,256.22	140.46
Total Assets	1,492.41	7,246.72	4,427.30	3,938.74	481.01
Total Debt*	2.93	2,309.68	0.00	0.00	70.53
Net Current Assets	710.79	-537.25	309.20	768.45	30.92
Contingent Liabilities	10.71	51.57	318.60	204.54	--

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Cash From Operating Activities	138.72	537.99	438.30	200.45	49.26
Cash Flow from Investing Activities	-38.28	-369.46	-11.30	-109.93	-28.35
Cash from Financing Activities	-89.21	-313.53	-447.90	-93.33	-20.96
Net Cash Inflow / Outflow	11.23	-145.00	-20.90	-2.80	-0.05

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
ROCE (%)	17.40	14.47	55.46	15.93	12.52
ROE (%)	12.11	19.23	44.50	11.81	10.04
ROA (%)	9.70	9.18	7.18	7.42	6.80
EBIT Margin (%)	25.62	36.04	27.81	21.17	28.44
Net Margin (%)	13.27	20.57	17.59	12.32	12.00
Cash Profit Margin (%)	17.37	28.49	17.51	15.24	21.47

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Revenue Growth (%)	14.50	8.15	-8.73	2.98	41.76
EBIT Growth (%)	45.59	8.91	0.73	10.63	40.32
Net Profit Growth (%)	49.27	72.82	4.14	5.49	74.18
EPS Growth (%)	52.57	73.16	4.14	5.49	71.83
Book Value Growth (%)	13.14	36.71	-14.39	8.94	14.81

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Price / Earnings	17.66	29.02	28.81	18.58	36.38
Price / Book Value	1.93	4.62	13.89	2.10	3.42
Dividend Yield (%)	0.70	0.00	3.01	1.56	0.00
EV/EBITDA	8.91	17.93	17.88	11.27	16.48
Market Cap (₹ Cr)	2,280.33	17,980.08	9,410.98	5,229.56	1,109.05

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Debt to Equity	0.00	0.59	0.00	0.00	0.22
Short term debt to equity ratio	0.00	0.12	--	--	0.07
Current Ratio	4.02	0.76	1.12	2.58	1.28
Quick Ratio	3.38	0.56	1.00	1.85	0.64
Interest Coverage	16.79	4.31	262.59	76.13	5.81

	Bliss GVS Pharma	Eris Lifesciences	Sanofi India	FDC	Sakar Healthcare
Debtors to sales (%)	55.79	21.74	9.62	6.99	19.90
Asset Turnover	0.70	0.46	0.46	0.59	0.56
Receivable days	180.13	63.88	35.69	21.28	58.58
Inventory Days	52.09	43.27	71.21	59.64	82.38
Payable days	75.40	151.85	122.11	105.74	107.49
Cash Conversion Cycle	156.82	-44.70	-15.20	-24.83	33.48

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.